Difference between revisions of "BanLec"
From Wikiwel
(Created page with "See also : Bananas ==Special Precautions of BanLec== ==Benefits and uses of BanLec are== Category:Treatments") |
|||
| (5 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
| + | Other Names : BanLec-I, Banana lectin<br> is a lectin from the jacalin-related lectin family isolated from the fruit of the bananas Musa acuminata and Musa balbisiana.BanLec is one of the predominant proteins in the pulp of ripe bananas[3] and has binding specificity for mannose and mannose-containing oligosaccharides.<br> | ||
See also : [[Bananas]] | See also : [[Bananas]] | ||
==Special Precautions of BanLec== | ==Special Precautions of BanLec== | ||
==Benefits and uses of BanLec are== | ==Benefits and uses of BanLec are== | ||
| + | * HIV : In 2010, BanLec was reported to be a potent inhibitor of HIV replication.Researchers at the University of Michigan determined that BanLec bound to the HIV-1 envelope protein gp120, which is high in sugar content, inhibiting viral entry into human cells.The researchers suggest that such an inhibitor of HIV infection may find use as a topical treatment, such as a vaginal microbicide, and may be cheaper to produce than current antiviral topical treatments. | ||
| + | * Cancer | ||
[[Category:Treatments]] | [[Category:Treatments]] | ||
Latest revision as of 01:22, 12 October 2013
Other Names : BanLec-I, Banana lectin
is a lectin from the jacalin-related lectin family isolated from the fruit of the bananas Musa acuminata and Musa balbisiana.BanLec is one of the predominant proteins in the pulp of ripe bananas[3] and has binding specificity for mannose and mannose-containing oligosaccharides.
See also : Bananas
Special Precautions of BanLec
Benefits and uses of BanLec are
- HIV : In 2010, BanLec was reported to be a potent inhibitor of HIV replication.Researchers at the University of Michigan determined that BanLec bound to the HIV-1 envelope protein gp120, which is high in sugar content, inhibiting viral entry into human cells.The researchers suggest that such an inhibitor of HIV infection may find use as a topical treatment, such as a vaginal microbicide, and may be cheaper to produce than current antiviral topical treatments.
- Cancer
